What is the recommended dilution and administration protocol for intravenous (IV) injection of Avil (pheniramine)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Dilution and Administration of Avil (Pheniramine) for IV Injection

Dilute pheniramine in at least 10 mL of 0.9% sodium chloride or 5% dextrose and administer slowly over 2-5 minutes to prevent seizures and hypotension. 1, 2

Recommended Dilution Protocol

  • Dilute 1-2 mg/kg (maximum 50 mg) in 10 mL of either 0.9% sodium chloride or 5% dextrose in water before IV administration 1, 2
  • The minimum dilution volume of 10 mL is critical—never administer undiluted IV push 2
  • Both normal saline and D5W are acceptable diluents with equivalent safety profiles 2

Administration Rate and Technique

  • Administer the diluted solution slowly over 2-5 minutes minimum 1, 2
  • Rapid administration significantly increases the risk of seizures, hypotension, and respiratory suppression 1, 2
  • Monitor vital signs and oxygen saturation continuously during and after administration 1

Dosing Parameters

  • Adult and pediatric dose: 1-2 mg/kg per dose (maximum initial dose: 50 mg) 1, 2
  • The IM route is acceptable when IV access is not immediately available, using the same dose 1
  • For ongoing allergic conditions, oral dosing of 4-12 mg as a single nocturnal dose may be used 1

Critical Safety Considerations

Immediate Risks with Rapid Administration

  • Seizures are the most serious acute complication of rapid IV push 1, 2
  • Hypotension can occur, particularly with undiluted or rapid administration 1, 2
  • Respiratory suppression and apnea, especially when combined with benzodiazepines or opioids 1, 2
  • Paradoxical excitement or agitation, particularly in pediatric patients 1, 2

Role in Anaphylaxis Management

  • Pheniramine should NEVER be used as monotherapy in anaphylaxis—epinephrine must be given first 2
  • Pheniramine serves only as adjunctive second-line therapy after epinephrine and fluid resuscitation 1, 2
  • Combination with H2-blockers (ranitidine 1 mg/kg diluted in 20 mL D5W over 5 minutes) is superior to H1-antihistamine alone in managing infusion reactions 3, 2

Common Clinical Pitfalls to Avoid

  • Never give undiluted IV push—always dilute in at least 10 mL of compatible solution 2
  • Never administer rapidly—use a minimum 2-minute infusion time to prevent seizures 1, 2
  • Never use as monotherapy in anaphylaxis—epinephrine must be given first 2
  • Monitor for respiratory depression, especially when combined with other sedative agents 1, 2
  • Sedation is the most common side effect and should be anticipated 1

Contraindications and Special Precautions

  • Avoid in severe hepatic disease, as sedative effects may precipitate hepatic coma 1
  • Contraindicated in angle-closure glaucoma, prostatic hypertrophy, and urinary retention 1
  • Avoid concomitant use with MAOIs and medications with anticholinergic effects 1
  • Should be avoided in pregnancy, especially during the first trimester 1
  • Should be avoided during lactation 1

Monitoring Requirements

  • Monitor vital signs continuously during administration 1
  • Assess oxygen saturation and respiratory effort throughout the infusion 2
  • Be prepared to provide respiratory support if needed 1
  • Watch for paradoxical agitation, particularly in pediatric patients 1

References

Guideline

Management of Acute Drug Reactions with Pheniramine

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Pheniramine Maleate Administration Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.